OneSource Specialty Pharma reports consolidated net loss of Rs 68.85 crore in the December 2024 quarter
Net Loss of OneSource Specialty Pharma reported to Rs 68.85 crore in the quarter ended December 2024 as against net loss of Rs 130.16 crore during the previous quarter ended December 2023. Sales rose 598.38% to Rs 392.56 crore in the quarter ended December 2024 as against Rs 56.21 crore during the previous quarter ended December 2023.
Particulars | Quarter Ended | ||
Dec. 2024 | Dec. 2023 | % Var. | |
Sales | 392.56 | 56.21 | 598 |
OPM % | 36.48 | -18.68 | - |
PBDT | 102.78 | -35.36 | LP |
PBT | 34.02 | -54.88 | LP |
NP | -68.85 | -130.16 | 47 |

Why Gold Remains a Safe Haven Amid Global Economic Shifts in 2025
4 mins read . Sep 5, 2025

Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025

What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •